Published Date: 
Total Pages: 
Medical Devices
Report Id: MDHM617

Hemostats are a surgical process where the formation of blood clot takes place at the injury spot. Hemostats are clotting of blood by blocking it temporarily at the time of surgeries for halting and controlling of bleeding. Hemostats is used only when the bleeding of the patient is heavy or the loss of blood may cause serious health issues or the patient is suffering from trauma defects or congenital diseases. The use of hemostats should be carefully regulated, quick and localized. Extensive variety of uses, constant progression in product portfolio, innovative headway encouraging the end user and protection support to producers in advancing tissue sealants are the real main driving forces of worldwide hemostats market.


How Big is the Global Hemostats Market?


The Global Hemostats Market is expected to exceed more than US$ 2.9 Billion by 2022 at a CAGR of 6.2% in the given forecast period.


The major driving factors of Global Hemostats Market are as follows:


  • Growing surgery procedures
  • Increasing number of insurance providers
  • Advancements in the product portfolio
  • Wide range of applications


The restraining factors of Global Hemostats Market are as follows:


  • Expensive of hemostats devices
  • More options available in the market
  • Low knowledge and awareness of the product
  • Stringent regulatory rules to control and regulate


The Global Hemostats Market is segmented on the lines of its type, application, end user and regional. Based on type segmentation it covers dressings, therapy device, and active wound care. Based on application segmentation it covers surgical wounds, ulcers, pressure ulcers, diabetic foot ulcers, venous ulcers, others. Based on end user segmentation it covers inpatient facilities, outpatient facilities. The Global Hemostats Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.


This report provides:
1) An overview of the global market for Global Hemostats Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Global Hemostats Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.



The scope of the report includes a detailed study of global and regional markets on Global Hemostats Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Johnson & Johnson Services, Inc. (U.S.). C. R. Bard, Inc. (U.S.), Baxter (U.S.), B Braun Melsungen AG (Germany), Pfizer Inc. (U.S.), Vascular Solutions, Inc. (U.S.), Gelita Medical GmbH (Germany), Equimedical (Netherlands), Integra Lifesciences Holdings Corporation (U.S.), Z-Medica, LLC (U.S.), and Marine Polymer Technologies, Inc. (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.


The Global Hemostats Market has been segmented as below: (Accordingly)


By Type Analysis:

  • Dressings
  • Therapy Device
  • Active Wound Care


By Application Analysis:

  • Surgical Wounds
  •  Ulcers
  • Pressure Ulcers
  • Diabetic Foot Ulcers
  • Venous Ulcers
  • Others


By End-User Analysis:

  • Inpatient Facilities
  • Outpatient Facilities


By Regional Analysis:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World


Reasons to Buy this Report:
1) Obtain the most up to date information available on all  Global Hemostats Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Hemostats Market data.
4) Assess your competitor’s refining portfolio and its evolution.


We can offer you custom research reports as per client’s special requirement.

    1.1    KEY TAKE AWAYS    
    1.3    MARKETS COVERED    
    1.4    STAKEHOLDERS    
    1.5.1    MARKET SIZE    
    1.5.2    MARKET SHARE    

2 Research Methodology 
    2.1 Integrated Ecosystem of the Market 
           2.1.1 Top-Down Approach
           2.1.2 Bottom-Up Approach
           2.1.3 Macro Indicator- Based Approach
           2.1.4 Unit Price Analysis
           2.1.5 Product Matrix
           2.1.6 Porter’s Five Forces Model
           2.1.7 Life Expectancy Rate
    2.2 Assumptions

3 Executive Summary 

4 Market Overview 
    4.1 Introduction 
    4.2 Market Drivers and Inhibitors 
    4.3 Key Market Dynamics

5 Hemostats Market, By Product Type 
    5.1 Introduction 
           5.1.1 Thrombin Based Hemostats
           5.1.2 Oxidized Regenerated Cellulose Based Hemostats
           5.1.3 Combination Hemostats
           5.1.4 Gelatin Based Hemostats
           5.1.5 Collagen Based Hemostats

6 Hemostats Market, By Geography 
    6.1 Introduction 
    6.2 Americas 
           6.2.1 U.S.
           6.2.2 Canada
           6.2.3 Mexico
           6.2.4 Brazil
           6.2.5 Argentina
           6.2.6 Chile
           6.2.7 Colombia
           6.2.8 Paraguay
           6.2.9 Uruguay
    6.3 Europe 
           6.3.1 Germany
           6.3.2 France
           6.3.3 U.K.
           6.3.4 Italy
           6.3.5 Spain
           6.3.6 Russia
           6.3.7 Switzerland
           6.3.8 The Netherlands
           6.3.9 Belgium
           6.3.10 Denmark
           6.3.11 Turkey
    6.4 Asia-Pacific 
           6.4.1 Japan
           6.4.2 China
           6.4.3 India
           6.4.4 Australia
           6.4.5 Republic of Korea
           6.4.6 Thailand
           6.4.7 Singapore
           6.4.8 Vietnam
           6.4.9 Taiwan
           6.4.10 Malaysia
           6.4.11 Indonesia
           6.4.12 New Zealand
    6.5 Middle East & Africa (MEA) 
           6.5.1 Egypt
           6.5.2 Saudi Arabia
           6.5.3 UAE
           6.5.4 Israel
           6.5.5 Oman
           6.5.6 Kuwait
           6.5.7 Zimbabwe
           6.5.8 Kenya
           6.5.9 Jordan
           6.5.10 Algeria
           6.5.11 Morocco
           6.5.12 Libya
           6.5.13 Tunisia
           6.5.14 Sudan
           6.5.15 South Africa
           6.5.16 Mauritius

7 Competitive Landscape 
    7.1 Company Share Analysis 
           7.1.1 U.S
           7.1.2 Canada
           7.1.3 Brazil
           7.1.4 Germany
           7.1.5 France
           7.1.6 U.K.
           7.1.7 China
           7.1.8 India
           7.1.9 Japan
    7.2 Product Launches 
    7.3 Mergers and Acquisitions 
    7.4 Collaborations, Joint Agreements & Expansions, Partnerships 
    7.5 Approvals, Alliances, Relocations & Licensing, and New Brand Strategy

License Format Properties
Single User License The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Multi User License The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user license, allowing up to five users to have access to the product.
Corporate License The report will be emailed to you. The report is sent in PDF format. This is a 10+ user license, allowing up to 10+ users to have access to the product.
Mini Report License In this you will receive full report except the Company Profile section of this report. In this you will receive full report except the Company Profile section of this report.
Need More Information: 


Toll Free No. : +1-855-984-1862

Call Us. : +91 86 05 657204